PL
PL · PL · PL-100381772
Glyxambi
ATC A10BD19
Last synced from URPL (Poland) on
Identification
ManufacturerBoehringer Ingelheim International GmbH
CountryPL (PL)
ATC codeA10BD19
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 9
- gtin05909991308636
- gtin05909991308643
- gtin05909991308650
- gtin05909991308667
- gtin05909991308674
- gtin05909991308681
- gtin05909991308698
- gtin05909991308704
- gtin05909991308711
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "25 mg + 5 mg",
"packaging": "05909991308636 ¦ Rp ¦ EU/1/16/1146/010 ¦ 119377\n7 tabl.\n05909991308643 ¦ Rp ¦ EU/1/16/1146/011 ¦ 119378\n10 tabl.\n05909991308650 ¦ Rp ¦ EU/1/16/1146/012 ¦ 119379\n14 tabl.\n05909991308667 ¦ Rp ¦ EU/1/16/1146/013 ¦ 119380\n28 tabl.\n05909991308674 ¦ Rp ¦ EU/1/16/1146/014 ¦ 119381\n30 tabl.\n05909991308681 ¦ Rp ¦ EU/1/16/1146/015 ¦ 119382\n60 tabl.\n05909991308698 ¦ Rp ¦ EU/1/16/1146/016 ¦ 119383\n70 tabl.\n05909991308704 ¦ Rp ¦ EU/1/16/1146/017 ¦ 119384\n90 tabl.\n05909991308711 ¦ Rp ¦ EU/1/16/1146/018 ¦ 119385\n100 tabl.",
"substance": "Empagliflozinum 25 mg + Linagliptinum 5 mg",
"common_name": "Empagliflozinum + Linagliptinum",
"pl_product_id": "100381772",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code A10BD19.
- NOGlyxambiBoehringer Ingelheim International GmbH
- 🇨🇭Glyxambi
- PLGlyxambiBoehringer Ingelheim International GmbH
- 🇨🇭GlyxambiBoehringer Ingelheim (Schweiz) GmbH
- DKGlyxambiBoehringer Ingelheim Int. GmbH
- ISGlyxambiBoehringer Ingelheim International GmbH*
- ISGlyxambiBoehringer Ingelheim International GmbH*
- NOGlyxambiBoehringer Ingelheim International GmbH
Access this data programmatically
Query Glyxambi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.